Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Reexamination Certificate
2001-04-13
2004-08-17
Mendez, Manuel (Department: 3763)
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
C604S117000
Reexamination Certificate
active
06776776
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates generally to delivery devices for delivering substances such as drugs, vaccines and the like, and more specifically relates to a drug delivery device having a needle cannula and a limiter for engaging the surface of the skin and limiting penetration of the tip of the needle cannula into the skin. More specifically, the present invention relates to a limiter capable of fixing the orientation of the needle cannula in a generally perpendicular plane to the skin engaging surface of the limiter and capable of enclosing the needle cannula subsequent to administering the intradermal injection.
BACKGROUND OF THE INVENTION
Intradermal injections are used for delivering a variety of substances. Many of these substances have proven to be more effectively absorbed into or react with the immune response system of the body when injected intradermally. Recently, clinical trials have shown that hepatitis B vaccines administered intradermally are more imunogenic if administered intramuscularly. In addition, substances have been injected intradermally for diagnostic testing, such as, for example using what is known in the art as the “Mantoux test” to determine the immunity status of the animal against tuberculosis and the immediate hypersensitivity status of Type I allergic diseases.
An intradermal injection is made by delivering the substance into the epidermis and upper layers of the dermis. Below the dermis layer is subcutaneous tissue (also sometimes referred to as the hypodermis layer) and muscle tissue, in that order. There is considerable variation in the skin thickness both between individuals and within the same individual at different sites of the body. Generally, the outer skin layer, epidermis, has a thickness between 50-200 microns, and the dermis, the inner and thicker layer of the skin, has a thickness between 1.5-3.5 mm. Therefore, a needle cannula that penetrates the skin deeper than about 3.0 mm has a potential of passing through the dermis layer of the skin and making the injection into the subcutaneous region, which may result in an insufficient immune response, especially where the substance to be delivered intradermally has not been indicated for subcutaneous injection. Also, the needle cannula may penetrate the skin at too shallow a depth to deliver the substance and result in what is commonly known in the art as a “wet injection” because of reflux of the substance from the injection site.
The standard procedure for making an intradermal injection is known to be difficult to perform, and therefore dependent upon experience and technique of the healthcare worker. This procedure is recommended to be performed by stretching the skin, orienting the bevel of a 26 Gauge short bevel needle cannula upwardly and inserting the needle cannula to deliver a volume of 0.5 ml or less of the substance into the skin of an animal with the needle cannula being inserted into the skin at an angle varying from around 10-15 degrees relative to the plane of the skin to form a blister or wheal in which the substance is deposited or otherwise contained. Accordingly, the technique utilized to perform the standard intradermal injection is difficult and requires the attention of a trained nurse or medical doctor. This procedure also makes it essentially impossible to self-administer an intradermal injection. Inserting the needle to a depth greater than about 3.0 mm typically results in a failed intradermal injection because the substance being expelled through the cannula will be injected into the subcutaneous tissue of the animal. Further, the standard method is not suitable for self-administration of intradermal injections.
Further, with the advent of viral infections that are transferred through contact with bodily fluids, it is desirable to enclose or conceal a needle cannula subsequent to administering an injection. Preferably, a delivery device should include a mechanism that is capable of enclosing a needle cannula immediately subsequent to administering the injection. If a needle is left uncovered for even a short period of time after administering an injection, such as, for example, while trying to reattach a needle cap, a biohazard exists. Therefore, it is desirable to provide an intradermal delivery device with a means for enclosing the needle cannula that is simply designed, easy to use, and readily available immediately after administering an injection.
Accordingly, there has been a need for a delivery device providing the ability of performing an intradermal injection of substances which overcomes the problems and limitations associated with conventional devices which may also be self-administered. Further, there has been a need to provide the delivery device with the ability to enclose a needle cannula immediately subsequent to administering the intradermal injection. The combination of these two features in the same delivery device would provide the ability to both reduce the probability of error and pain caused from the intradermal injection and to conceal the needle cannula after the injection has been administered.
SUMMARY OF THE INVENTION AND ADVANTAGES
In contrast to the devices discussed above, the present invention both enables the administration of an intradermal injection utilizing a simplified method that reduces the probability of error and also enables the user to enclose the needle immediately after administering the injection.
An intradermal delivery device for use in intradermally injecting substances into the skin of an animal includes a prefillable reservoir adapted to contain the substance. An outlet port is in fluid communication with the reservoir. A needle cannula is in fluid communication with the outlet port and includes a forward tip extending away from the delivery device. The forward tip is adapted for penetrating the skin of an animal. A limiter portion surrounds the needle cannula and includes a generally flat skin engaging surface extending in a plane generally perpendicular to an axis of the needle cannula. A hub portion is secured around the needle cannula and defines a locator for the limiter to position the limiter upon the device. The skin engaging surface is adapted to be placed against skin of an animal to administer an intradermal injection of the substance. The forward tip of the cannula extends beyond the skin engaging surface a distance equal to approximately 0.5 mm to 3 mm such that the limiter limits penetration of the needle cannula to the dermis layer of the skin of the animal thereby enabling injection of the substance into the dermis layer of the animal. An enclosure means encloses the needle cannula following the intradermal injection.
The present invention provides the desirable features set forth above that are not presently included together on the same needle assembly. The limiter allows an intradermal injection to be made at a generally perpendicular angle to the angle to the skin of the animal and then also encloses the needle subsequent to administering the injection.
REFERENCES:
patent: 1934046 (1933-11-01), Demarchi
patent: 2876770 (1959-03-01), White
patent: 3073306 (1963-01-01), Linder
patent: 3400715 (1968-09-01), Pederson
patent: 3890971 (1975-06-01), Leeson et al.
patent: 4060073 (1977-11-01), Collica et al.
patent: 4270537 (1981-06-01), Romaine
patent: 4373526 (1983-02-01), Kling
patent: 4583978 (1986-04-01), Porat et al.
patent: 4596556 (1986-06-01), Morrow et al.
patent: 4769003 (1988-09-01), Stamler
patent: 4790824 (1988-12-01), Morrow et al.
patent: 4883573 (1989-11-01), Voss et al.
patent: 4886499 (1989-12-01), Cirelli et al.
patent: 4898588 (1990-02-01), Roberts
patent: 4940460 (1990-07-01), Casey, I. et al.
patent: 4941880 (1990-07-01), Burns
patent: 4955871 (1990-09-01), Thomas
patent: 4978344 (1990-12-01), Dombrowski et al.
patent: 5015235 (1991-05-01), Crossman
patent: 5064413 (1991-11-01), McKinnon et al.
patent: 5071353 (1991-12-01), van der Wal
patent: 5137516 (1992-08-01), Rand et al.
patent: 5141496 (1992-08-01), Dalto et al.
patent: 5190521 (1993-03-01)
Alchas Paul G.
Guillermo Carlos E.
Heyman Peter W.
Korisch Marina S.
Laurent Philippe Emile Fernand
Becton Dickinson and Company
Hoffmann & Baron , LLP
Mendez Manuel
LandOfFree
Prefillable intradermal delivery device does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prefillable intradermal delivery device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prefillable intradermal delivery device will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3341283